03 March 2023 : Original article
Comparison of Biosimilar Filgrastim with Innovator Fligrastim for Peripheral Blood Stem Cells Mobilization, Collection of CD34+ Stem Cells, and Engraftment in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation: A Single-Center Experience
Maha M. Islami






DOI: 10.12659/AOT.938585
Ann Transplant 2023; 28:e938585